Top Markets
Coin of the day
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Rankning i aktier #5731
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Aktiekurs
$29.86
Senast synkroniserad: 2026-08-19
Marknadsvärde
$2.48B
Förändring (1 dag)
4.92%
Förändring (1 år)
502.82%
Land
TW
Handel Lin BioScience, Inc. (6696)

Kategori

Historik för aktiesplit för Lin BioScience, Inc. (6696)
Aktien Lin BioScience, Inc. (symbol: 6696) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 27, 2026.
En 6696-aktie köpt före Aug 27, 2026 motsvarar nu 0 6696-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH